Add BrightSurf on Google Email

Rubenstein Associates, Inc.


Lasker Foundation announces 2019 Lasker Awards

The 2019 Lasker Awards recognize Max D. Cooper and Jacques Miller for their discovery of the function of B and T cells in the adaptive immune system. The awards also honor H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their development of Herceptin, a monoclonal antibody therapy that targets HER2-positive breast cancer.

New NYUAD research finds 3D printers offer alternate method to create microfluidic probes

Researchers at NYU Abu Dhabi have developed a method to create microfluidic probes using 3D printing, which provides an effective and inexpensive technique for studying cancer cells. The new approach enables scientists to fabricate probes that can deliver reagents in a localized manner, allowing for targeted cell culture and analysis.

SourceRubenstein Associates, Inc.·JournalScientific Reports·DateAug 8, 2018